$0.02
(Market cap
$130 Mln
Revenue (TTM)
$317 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-20 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
21.06
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.3
-
Face value
--
-
Shares outstanding
11,180,703
10 Years Aggregate
CFO
$850.58 Mln
EBITDA
$1,019.14 Mln
Net Profit
$722.37 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MEDIFAST INC (MED)
| 13.9 | 23.7 | -3.0 | -13.3 | -47.6 | -44.4 | -10.5 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
MEDIFAST INC (MED)
| -39.4 | -73.5 | -41.7 | -44.9 | 9.4 | 86.2 | -9.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
MEDIFAST INC (MED)
|
12.2 | 129.9 | 316.9 | -25.6 | -3.7 | -13 | -- | 0.7 |
| 173.3 | 5,688.3 | 1,085.9 | 164.4 | 20.3 | 12.8 | 35.1 | 4.4 | |
| 42.1 | 2,741.6 | 3,084.1 | 166.3 | 8.7 | 10 | 16.2 | 1.6 | |
| 36.4 | 2,366.6 | 3,084.1 | 166.3 | 8.7 | 10 | 14 | 1.4 | |
| 66.9 | 10,705.4 | 6,555.5 | 597.9 | 14.7 | 11.8 | 18 | 2.0 | |
| 70.3 | 3,403.5 | 1,177.3 | 203.5 | 13.4 | 16.6 | 18.3 | 2.8 | |
| 31.1 | 7,545.7 | 18,436.0 | 545.6 | 5.2 | 14.7 | 13.8 | 2.0 | |
| 83.5 | 3,573.7 | 8,412.5 | 293.0 | 9.7 | 8.9 | 14.5 | 1.2 | |
| 4,054.4 | 4,080.2 | 10,272.0 | 634.0 | 4.2 | 11.8 | 6.5 | 0.8 | |
| 40.5 | 3,132.0 | 734.7 | 95.5 | 17.7 | 10.1 | 32.6 | 3.3 |
Shareholding Pattern
View DetailsAbout MEDIFAST INC (MED)
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy... living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland. Read more
-
Executive Chairman & CEO
Mr. Daniel R. Chard
-
Executive Chairman & CEO
Mr. Daniel R. Chard
-
Headquarters
Baltimore, MD
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for MEDIFAST INC (MED)
What is the current share price of MEDIFAST INC (MED) Today?
The share price of MEDIFAST INC (MED) is $12.16 (NYSE) as of 01-Sep-2026 15:39 EDT. MEDIFAST INC (MED) has given a return of -47.56% in the last 3 years.
What is the current PB & PE ratio of MEDIFAST INC (MED)?
Since, TTM earnings of MEDIFAST INC (MED) is negative, P/E ratio is not available.
The P/B ratio of MEDIFAST INC (MED) is 0.66 times as on 21-Aug-2026, a 61 discount to its peers’ median range of 1.69 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-6.29 |
0.59 |
2024 |
92.55 |
0.92 |
2023 |
7.39 |
3.65 |
2022 |
8.91 |
8.25 |
2021 |
15.05 |
12.19 |
What is the 52 Week High and Low of MEDIFAST INC (MED)?
The 52-week high and low of MEDIFAST INC (MED) are Rs 14.67 and Rs 9.22 as of 02-Sep-2026.
What is the market cap of MEDIFAST INC (MED)?
MEDIFAST INC (MED) has a market capitalisation of $ 130 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in MEDIFAST INC (MED)?
Before investing in MEDIFAST INC (MED), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.